Implantable living materials autonomously deliver therapeutics using contained engineered bacteria
Science · 14.05.2026 · 392 (6799) · 729-734
DOI: 10.1126/science.aec2071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 14.05.2026. Verfasst von Tetsuhiro Harimoto und 16 weiteren Autor:innen. Beteiligte Einrichtung: John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Delivery Systems, Escherichia coli, Prostheses and Implants. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: National Science Foundation, National Institutes of Health, National Cancer Institute.
Abstract (Originalsprache)
Microbes are increasingly used as living therapeutics, yet their uncontrolled dissemination in the body has remained a clinical roadblock. Physical containment remains largely unattainable owing to eventual bacteria escape. In this work, we present an implantable material that encapsulates and confines bacteria, wherein synthetically engineered microbes produce therapeutic payloads from within. We developed a hydrogel scaffold with dual mechanical features: high stiffness to regulate bacterial proliferation and high toughness to resist material fracture under physiological stress. This design achieved complete bacterial containment for 6 months and withstood multiple forms of mechanical loading that otherwise caused catastrophic material failure. By genetically engineering embedded bacteria, we endowed the material with environmental sensing and on-demand therapeutic release capabilities and demonstrated autonomous treatment in a murine prosthetic joint infection model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
- Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.
- Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Physics, Harvard University, Cambridge, MA, USA.
ORCID-Profile: Tetsuhiro Harimoto, Fernando Herrero Quevedo, Janis Zillig, Sanjay Schreiber, Christine Heera Ahn, Tania To, Rohan Thakur, Alexander M Tatara, Shawn Kang, Zheqi Chen, Nuria Lafuente-Gómez, Blake Hanan, Alexander Pauer, Shanda Lightbown, David A Weitz, David J Mooney
Förderung
- National Science Foundation
- National Institutes of Health
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- Materials Research Science and Engineering Center, Harvard University
- CRIS Cancer Foundation
- Hansjörg Wyss Institute for Biologically Inspired Engineering, Harvard University
Zitieren
APA
Harimoto, T., Herrero Quevedo, F., Zillig, J., Schreiber, S., Wu, Y., Ahn, C. H., To, T., Thakur, R., Tatara, A. M., Kang, S., Chen, Z., Lafuente-Gómez, N., Hanan, B., Pauer, A., Lightbown, S., Weitz, D. A., & Mooney, D. J. (2026). Implantable living materials autonomously deliver therapeutics using contained engineered bacteria. Science, 392(6799), 729-734. https://doi.org/10.1126/science.aec2071
Vancouver
Harimoto T, Herrero Quevedo F, Zillig J, Schreiber S, Wu Y, Ahn CH, et al. Implantable living materials autonomously deliver therapeutics using contained engineered bacteria. Science. 2026;392(6799):729-734. doi:10.1126/science.aec2071
BibTeX
@article{Harimoto2026,
author = {Harimoto, Tetsuhiro and Herrero Quevedo, Fernando and Zillig, Janis and Schreiber, Sanjay and Wu, Yi and Ahn, Christine Heera and To, Tania and Thakur, Rohan and Tatara, Alexander M and Kang, Shawn and Chen, Zheqi and Lafuente-Gómez, Nuria and Hanan, Blake and Pauer, Alexander and Lightbown, Shanda and Weitz, David A and Mooney, David J},
title = {Implantable living materials autonomously deliver therapeutics using contained engineered bacteria},
journal = {Science},
year = {2026},
volume = {392},
number = {6799},
pages = {729--734},
doi = {10.1126/science.aec2071}
}
EUVIMED